Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Circulation. Cardiovascular Interventions|September 24, 2025
Aspirin Versus Clopidogrel Beyond 1 Month After PCI in Patients With Oral AnticoagulationMasahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 24, 2024
An aspirin-free strategy for percutaneous coronary intervention in patients with diabetes: a pre-specified subgroup analysis of the STOPDAPT-3 trialKo Yamamoto, Masahiro Natsuaki, Hirotoshi Watanabe, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 25, 2025
Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trialTakenori Domei, Ko Yamamoto, Masahiro Natsuaki, et al.
The American Journal of Cardiology|July 8, 2023
Post-contrast Acute Kidney Injury After Emergent and Elective Percutaneous Coronary Intervention (from the CREDO-Kyoto PCI/CABG Registry Cohort 3)Kazuhisa Kaneda, Hiroki Shiomi, Mitsuru Abe, et al.
The American Journal of Cardiology|July 30, 2023
The Impact of Mitral Regurgitation on Long-Term Outcomes in Acute Myocardial Infarction Undergoing Percutaneous Coronary InterventionYuki Obayashi, Hiroki Shiomi, Takeshi Morimoto, et al.
The American Journal of Cardiology|August 16, 2022
Stroke Risk Stratification With the CHADS2 Score in Patients Without Atrial Fibrillation Who Underwent Percutaneous Coronary InterventionYuki Obayashi, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 18, 2026
Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes - Prespecified Subgroup Analysis of the STOPDAPT-3 TrialKenji Kanenawa, Ko Yamamoto, Takenori Domei, et al.
JACC. Cardiovascular Interventions|January 4, 2023
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary InterventionKo Yamamoto, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Circulation|November 23, 2023
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized TrialMasahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, et al.
European Heart Journal|August 31, 2024
Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trialHirotoshi Watanabe, Masahiro Natsuaki, Takeshi Morimoto, et al.
Pageof 6